Table 3.
Extended vs no/standard pelvic LND.
| No/standard pelvic LND, n (%) | Extended pelvic LND, n (%) | Total, n (%) | OR (95% CI) | P | |
|---|---|---|---|---|---|
| Age group, years: | |||||
| ≤60 | 94 (29) | 120 (27) | 214 (28) | Reference 1.0 | |
| 61–70 | 108 (34) | 147 (33) | 255 (33) | 1.07 (0.74–1.54) | 0.732 |
| 71–80 | 98 (31) | 135 (30) | 233 (31) | 1.08 (0.74–1.57) | 0.691 |
| ≥81 | 19 (6) | 41 (9) | 60 (8) | 1.69 (0.92–3.10) | 0.090 |
| Sex: | |||||
| Male | 259 (81) | 345 (78) | 604 (79) | Reference 1.0 | |
| Female | 61 (19) | 100 (22) | 161 (21) | 1.23 (0.86–1.76) | 0.254 |
| Preoperative T stage: | |||||
| ≤T1 or CIS | 103 (37) | 100 (30) | 203 (33) | Reference 1.0 | |
| T2 | 142 (52) | 197 (59) | 338 (56) | 1.43 (1.01–2.03) | 0.045 |
| ≥T3 | 30 (11) | 36 (11) | 66 (11) | 1.24 (0.71–2.16) | 0.456 |
| Case number: | |||||
| 1–10 | 85 (26) | 67 (15) | 152 (20) | Reference 1.0 | |
| 11–25 | 98 (31) | 95 (21) | 193 (25) | 1.23 (0.82–1.97) | 0.342 |
| 26–50 | 84 (26) | 97 (22) | 181 (24) | 1.46 (0.95–2.26) | 0.084 |
| ≥51 | 53 (17) | 186 (42) | 239 (31) | 4.45 (2.86–6.93) | <0.001 |
| Surgeon volume, n: | |||||
| 1–10 | 19 (7) | 29 (7) | 48 (7) | Reference 1.0 | |
| 11–50 | 230 (86) | 153 (34) | 383 (54) | 0.44 (0.24–0.80) | 0.008 |
| ≥51 | 18 (7) | 262 (59) | 199 (39) | 9.53 (4.50–20.2) | <0.001 |
| Institution volume, n: | |||||
| ≤100 | 298 (92) | 259 (58) | 557 (73) | Reference 1.0 | |
| ≥101 | 22 (7) | 186 (42) | 208 (27) | 9.72 (6.07–16.60) | <0.001 |
| Pathological stage: | |||||
| ≤T2 | 197 (63) | 247 (56) | 444 (59) | Reference 1.0 | |
| T3 | 79 (25) | 146 (33) | 225 (30) | 1.47 (1.06–2.05) | 0.022 |
| T4 | 37 (12) | 49 (11) | 86 (11) | 1.05 (0.66–1.68) | 0.818 |
| LN status: | |||||
| Negative | 228 (75) | 320 (72) | 548 (73) | Reference 1.0 | |
| Positive | 75 (25) | 123 (28) | 198 (27) | 1.16 (0.84–1.63) | 0.360 |